메뉴 건너뛰기




Volumn 16, Issue 4 SUPPL., 2001, Pages 113-123

Involvement of nicotinic acetylcholine receptors in the protection of dopamine terminals in experimental Parkinsonism

Author keywords

6 hydroxydopamine; Dopamine; nACHRs; Parkinson's disease; Striatum; Substantia nigra

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CHLORISONDAMINE; DOPAMINE; LEVODOPA; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; NEUROPROTECTIVE AGENT; NEUROTOXIN;

EID: 0035544933     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (13)

References (26)
  • 13
    • 0023808881 scopus 로고    scopus 로고
    • Chronic nicotine treatment counteracts the disappearance of tyrosine hydroxylase-inmunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection
    • (1998) Brain Res , vol.455 , pp. 332-345
    • Janson, A.M.1    Fuxe, K.2    Agnati, L.F.3
  • 22
  • 23
    • 0030827671 scopus 로고    scopus 로고
    • Nicotine protects cultured cortical neurones against glutamate-induced cytotoxicity via alpha-7 neuronal receptors and neuronal CNS receptors
    • (1997) Brain Res , vol.765 , pp. 135-140
    • Kaneko, S.1    Maeda, T.2    Kume, T.3
  • 25
    • 0029656194 scopus 로고    scopus 로고
    • Chronic continuous infusion of (-) nicotine reduces basic fibroblast growth factor mRNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat
    • (1996) Neuroscience , vol.70 , pp. 169-177
    • Blum, M.1    Wu, G.2    Mudò, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.